Industry Trend Analysis - Pharmaceutical Price Regulation To Benefit Drugmakers - AUG 2017

BMI View: Elevated drug prices in Malaysia will continue to drive demand for pharmaceutical price regulation given the current lack of adequate regulation . T he government has proposed a policy which it hopes will control prices; this will be positive for both the drugmakers and patients, enabling greater access to medicines.

While several proposals have been put forward by Malaysia's Ministry of Health to suggest price-control policies such as separating drug prescription and dispensing of medicines to reduce price mark-ups, high medicine prices remain a long-standing problem in Malaysia. As such, the Malaysian government will continue to intervene and establish pharmaceutical price controls to increase the population's access to affordable medicines. This is in accordance with the country's National Medicines Policy, which aims to promote equitable access to essential medicines of good quality in order to improve the health and treatment of the population.

Proposed Legislation To Increase Transparency In Drug Prices

Opportunities In Patented And Generic Medicine Sector
Subsector Market Share (% of total)
f = BMI forecast. Source: BMI

This article is part of our Asia coverage. To access this article subscribe now or sign up for free trial